NASDAQ: TEMTempus Ai Inc Stock
$71.28+0.05 (+0.07%)
Updated Jun 13, 2025
TEM Price
$71.28
Fair Value Price
-$45.25
Market Cap
$12.34B
52 Week Low
$22.89
52 Week High
$91.45
P/E
-10.32x
P/B
37.83x
P/S
10.24x
PEG
N/A
Dividend Yield
N/A
Revenue
$803.32M
Earnings
-$709.10M
Gross Margin
57.1%
Operating Margin
-86.72%
Profit Margin
-89.8%
Debt to Equity
3.73
Operating Cash Flow
-$193M
Beta
2.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TEM Overview
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TEM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Internet Content & Information
Industry Rating
B
TEM
Ranked#38 of 51
Ranked#38 of 51
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $24.66 | A | |
| $10.96 | A | |
| $18.17 | A |
Be the first to know about important TEM news, forecast changes, insider trades & much more!
TEM News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TEM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TEM ($71.28) is overvalued by 257.54% relative to our estimate of its Fair Value price of -$45.25 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TEM ($71.28) is not significantly undervalued (257.54%) relative to our estimate of its Fair Value price of -$45.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TEM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TEM due diligence checks available for Premium users.
Valuation
TEM fair value
Fair Value of TEM stock based on Discounted Cash Flow (DCF)
Price
$71.28
Fair Value
-$45.25
Undervalued by
257.54%
TEM ($71.28) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TEM ($71.28) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TEM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TEM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-10.32x
Industry
26.95x
Market
31.36x
TEM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
37.83x
Industry
6.61x
TEM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TEM's financial health
Profit margin
Revenue
$255.7M
Net Income
-$68.0M
Profit Margin
-26.6%
TEM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TEM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.5B
Liabilities
$1.2B
Debt to equity
3.73
TEM's short-term assets ($573.97M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TEM's long-term liabilities ($880.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TEM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$105.6M
Investing
-$375.8M
Financing
$293.0M
TEM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TEM vs Internet Content & Information Stocks
Tempus Ai Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.